v3.10.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Income:        
Revenue
Expenses:        
Research and development 20,057 62,075 62,157 322,882
General and administrative 158,908 173,023 592,037 769,842
Interest 100,858 96,427 293,636 220,091
Total expenses 279,823 331,525 947,830 1,312,815
Gain on settlement of accounts payable 139,789
Net loss $ (279,823) $ (331,525) $ (808,041) $ (1,312,815)
Loss per share:        
Basic and diluted (in dollars per share) $ (0.004) $ (0.01) $ (0.012) $ (0.088)
Weighted average shares outstanding, basic and diluted (in shares) 68,146,829 34,826,497 67,726,410 14,901,620

Source